気道陽圧デバイスの世界市場：洞察、競合情勢、市場予測：2030年

世界の気道陽圧（PAP）デバイスの市場規模は、2020年に19億2,000万米ドルとなりました。同市場は、2024年から2030年の予測期間中に8.40％のCAGRで拡大し、2030年には31億2,000万米ドルに達すると予測されています。PAPデバイスの需要は、主に閉塞性睡眠時無呼吸症候群の有病率の増加、新生児呼吸窮迫症候群の有病率の増加、非侵襲的換気に対する需要の増加、デバイス開発における技術的進歩により成長が促進されています。

気道陽圧デバイス市場は、睡眠時無呼吸症候群の症例数の増加により、予測期間中にかなりの成長が見込まれます。Bhattらによって2020年に発表された「Global burden of sleep-disordered breathing and its implications」と題されたジャーナル「Respirology」に掲載された論文によると、世界人口の7分の1以上、つまり10億人が閉塞性睡眠時無呼吸症候群に苦しんでいると予測されています。

OSAに関連する主な危険因子の一つは肥満です。世界保健機関（WHO）の肥満に関するファクトシート（2023年）によると、世界の肥満は1975年以来3倍に増加しています。同じファクトシートによると、2016年には19億人以上が太りすぎで、そのうち6億5,000万人が肥満でした。2020年には、5歳以下の子ども3,900万人が肥満または過体重となります。太り過ぎは多くの健康への影響リスクを高め、その一つがOSAであるため、これはPAPデバイスの需要拡大に大きく影響する要因となる可能性があります。

PAPデバイスは、睡眠時無呼吸症候群の患者の気道を開いた状態に保ち、睡眠中に気道がつぶれるのを防ぐことで、正常な呼吸を可能にします。

当レポートでは、世界の気道陽圧デバイス市場について調査し、市場の概要とともに、デバイスタイプ別、年齢層別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 気道陽圧デバイス市場レポートのイントロダクション

第2章 気道陽圧デバイス市場のエグゼクティブサマリー

第3章 規制と特許の分析

• 米国
• 欧州
• 日本
• 中国

第4章 気道陽圧デバイス市場の主な要因分析

• 気道陽圧デバイス市場の促進要因
• 気道陽圧デバイス市場の抑制要因と課題
• 気道陽圧デバイス市場の機会

第5章 気道陽圧デバイス市場におけるポーターのファイブフォース分析

第6章 気道陽圧デバイス市場に対するCOVID-19の影響分析

第7章 気道陽圧デバイスの市場概要

• デバイスタイプ別
• 年齢層別
• エンドユーザー別
• 地域別

第8章 気道陽圧デバイス市場の企業と製品プロファイル

• ResMed
• Koninklijke Philips N.V
• Fisher & Paykel Healthcare Limited
• APEX MEDICAL CORP
• ARMSTRONG MEDICAL (an EAKIN Company)
• Smiths Medical
• Compumedics Limited
• VYAIRE MEDICAL, INC
• Somnera Inc
• 3B Medical Inc
• DeVilbiss Healthcare LLC
• Curative Medical Inc,
• Somnetics International, Inc.
• Lowenstein Medical UK Ltd.
• Beijing Aeonmed Co., Ltd.
• medin Medical Innovations GmbH
• medicraft
• Hebei Topson Medical Technology Ltd.
• Sefam
• Lowenstein Medical Technology GmbH + Co. KG

第9章 KOL の見解

第10章 プロジェクトのアプローチ

第11章 DelveInsightについて

第12章 免責事項とお問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: COVID-19 Impact Analysis
• Table 3: Positive Airway Pressure Devices in Global (2018-2030)
• Table 4: Positive Airway Pressure Devices in Global by Type of Devices (2018-2030)
• Table 5: Positive Airway Pressure Devices in Global by Age Group (2018-2030)
• Table 6: Positive Airway Pressure Devices in Global by End User (2018-2030)
• Table 7: Positive Airway Pressure Devices in Global by Geography (2018-2030)
• Table 8: Positive Airway Pressure Devices in North America (2018-2030)
• Table 9: Positive Airway Pressure Devices in North America by Country (2018-2030)
• Table 10: Positive Airway Pressure Devices in the US (2018-2030)
• Table 11: Positive Airway Pressure Devices in Canada (2018-2030)
• Table 12: Positive Airway Pressure Devices in Mexico (2018-2030)
• Table 13: Positive Airway Pressure Devices in Europe (2018-2030)
• Table 14: Positive Airway Pressure Devices in Europe by Country (2018-2030)
• Table 15: Positive Airway Pressure Devices in France (2018-2030)
• Table 16: Positive Airway Pressure Devices in Germany (2018-2030)
• Table 17: Positive Airway Pressure Devices in the United Kingdom (2018-2030)
• Table 18: Positive Airway Pressure Devices in Italy (2018-2030)
• Table 19: Positive Airway Pressure Devices in Spain (2018-2030)
• Table 20: Positive Airway Pressure Devices in Rest of Europe (2018-2030)
• Table 21: Positive Airway Pressure Devices in APAC (2018-2030)
• Table 22: Positive Airway Pressure Devices in APAC by Country (2018-2030)
• Table 23: Positive Airway Pressure Devices in China (2018-2030)
• Table 24: Positive Airway Pressure Devices in Japan (2018-2030)
• Table 25: Positive Airway Pressure Devices in India (2018-2030)
• Table 26: Positive Airway Pressure Devices in Australia (2018-2030)
• Table 27: Positive Airway Pressure Devices in South Korea (2018-2030)
• Table 28: Positive Airway Pressure Devices in Rest of APAC (2018-2030)
• Table 29: Positive Airway Pressure Devices in Rest of World (2018-2030)
• Table 30: Positive Airway Pressure Devices in RoW by Region (2018-2030)
• Table 31: Positive Airway Pressure Devices in Middle East (2018-2030)
• Table 32: Positive Airway Pressure Devices in Africa (2018-2030)
• Table 33: Positive Airway Pressure Devices in South America (2018-2030)

List of Figures

Figures 1: Competitive Analysis

Figures 2: COVID-19 Impact Analysis

Figures 3: Positive Airway Pressure Devices in Global (2018-2030)

Figures 4: Positive Airway Pressure Devices in Global by Type of Devices (2018-2030)

Figures 5: Positive Airway Pressure Devices in Global by Age Group (2018-2030)

Figures 6: Positive Airway Pressure Devices in Global by End User (2018-2030)

Figures 7: Positive Airway Pressure Devices in Global by Geography (2018-2030)

Figures 8: Positive Airway Pressure Devices in North America (2018-2030)

Figures 9: Positive Airway Pressure Devices in North America by Country (2018-2030)

Figures 10: Positive Airway Pressure Devices in the US (2018-2030)

Figures 11: Positive Airway Pressure Devices in Canada (2018-2030)

Figures 12: Positive Airway Pressure Devices in Mexico (2018-2030)

Figures 13: Positive Airway Pressure Devices in Europe (2018-2030)

Figures 14: Positive Airway Pressure Devices in Europe by Country (2018-2030)

Figures 15: Positive Airway Pressure Devices in France (2018-2030)

Figures 16: Positive Airway Pressure Devices in Germany (2018-2030)

Figures 17: Positive Airway Pressure Devices in the United Kingdom (2018-2030)

Figures 18: Positive Airway Pressure Devices in Italy (2018-2030)

Figures 19: Positive Airway Pressure Devices in Spain (2018-2030)

Figures 20: Positive Airway Pressure Devices in Rest of Europe (2018-2030)

Figures 21: Positive Airway Pressure Devices in APAC (2018-2030)

Figures 22: Positive Airway Pressure Devices in APAC by Country (2018-2030)

Figures 23: Positive Airway Pressure Devices in China (2018-2030)

Figures 24: Positive Airway Pressure Devices in Japan (2018-2030)

Figures 25: Positive Airway Pressure Devices in India (2018-2030)

Figures 26: Positive Airway Pressure Devices in Australia (2018-2030)

Figures 27: Positive Airway Pressure Devices in South Korea (2018-2030)

Figures 28: Positive Airway Pressure Devices in Rest of APAC (2018-2030)

Figures 29: Positive Airway Pressure Devices in Rest of World (2018-2030)

Figures 30: Positive Airway Pressure Devices in RoW by Region (2018-2030)

Figures 31: Positive Airway Pressure Devices in Middle East (2018-2030)

Figures 32: Positive Airway Pressure Devices in Africa (2018-2030)

Figures 33: Positive Airway Pressure Devices in South America (2018-2030)

Figures 34: Market Drivers

Figures 35: Market Barriers

Figures 36: Marker Opportunities

Figures 37: PORTER'S Five Force Analysis

Positive Airway Pressure Devices Market By Device Type (Continuous Positive Airway Pressure Devices, Autotitrating Poitive Airway Pressure Devices, And Bilevel Positive Airway Pressure Devices, And Others), By Age Group (Adults And Pediatrics), By End User (Hospitals, Clinics, And Homecare Settings), by geography is expected to grow at a steady CAGR (forecast period-2024-2030) owing to rising prevalence of obstructive sleep apnea and increasing prevalence of neonatal respiratory distress syndrome

Global Positive Airway Pressure Devices Market was valued at USD 1.92 billion in 2020, growing at a CAGR of 8.40% during the forecast period from 2024 to 2030 to reach USD 3.12 billion by 2030. The demand for PAP Devices is primarily witnessing growth on account of the increasing prevalence of obstructive sleep apnea, rising prevalence of neonatal respiratory distress syndrome, growing demand for noninvasive ventilation, and technological advancements in device development.

Positive Airway Pressure Devices Market Dynamics:

The positive airway pressure devices market is set to experience a considerable growth in the forecast period due to the increasing number of cases of sleep apnea. As per the article published in the Journal "Respirology" titled "Global burden of sleep-disordered breathing and its implications" published in 2020 by Bhatt et al, it has been estimated that over one-seventh of the world's population or one billion are predicted to suffer from obstructive sleep apnea.

As per a research study published in the Lancet Journal titled "Estimation of the global prevalence and burden of obstructive sleep apnea: a literature-based analysis" by Benjafield et al, in 2019, it was estimated that 936 million adults aged 30-69 years (men and women) had mild to severe obstructive sleep apnea and 425 million (399-450) adults aged 30-69 years had moderate to severe obstructive sleep apnea globally. The number of affected individuals was highest in China, followed by the USA, Brazil, and India.

One of the major risk factors associated with OSA is obesity. As per the factsheet provided by the World Health Organization on Obesity (2023), the worldwide obesity has tripled since 1975. As per the same factsheet, in 2016, over 1.9 billion people overweight in 2016, of which 650 million people were obese. In 2020, 39 million children below the age of 5 were either obese or overweight. As being overweight increases the risk of numerous health implications, one of them being OSA, this could be a major influencing factor in the growing demand for PAP devices.

PAP devices help in keeping the airways open for sleep apnea patients and prevent it from collapsing while they sleep thereby enabling them to breathe normally.

Furthermore, another factor aiding in the growth of the PAP devices market is the rising number of cases of the neonatal respiratory distress syndrome. As per an article published in journal "Pharmacy & Therapeutics", titled "Neonatal Respiratory Distress Syndrome: Tackling A Worldwide Problem" by Dyer (2019), the mortality rates associated with NRDS in poor countries are 10 times higher than wealthier countries. It further stated that the situation is not any better in wealthier countries as well, such as the United States where the mortality rates associated with NRDS reach as high as 60%.

Due to the drawbacks associated with mechanical ventilation, PAP devices are gaining popularity among end users in the treatment of infants suffering from NRDS.

Therefore, the abovementioned factors combined with others are expected to drive the growth of the PAP devices market.

However, frequent product recalls due to increasing risk of infections associated with PAP devices, may limit the positive airway pressure devices market growth over the forecast period.

Positive Airway Pressure Devices Market Segment Analysis:

Positive Airway Pressure Devices market by Device Type (Continuous Positive Airway Pressure Devices, Auto titrating Positive Airway Pressure Devices, Bilevel Positive Airway Pressure Devices, and Others), Positive Airway Pressure Devices market by Age Group (Adults and Pediatrics), Positive Airway Pressure Devices market by End User (Hospitals, Clinics, and Homecare Settings), and Positive Airway Pressure Devices market by Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the device type segment of the PAP devices market, Continuous Positive Airway Pressure Devices are predicted to account for the largest market share compared to other device types. This can be attributed to the fact that CPAP devices are prescribed as the first line PAP therapy to patients. Another factor that adds to their popularity is the simplistic design of the device, which provides a steady pressure rate for both inhalation and exhalation. Furthermore, as CPAP devices have the most basic design and functionality, they cost significantly less than the counterparts, thereby contributing in their increased demand in the PAP devices market. Moreover, compared to other types of PAP devices, CPAP devices are covered by majority of the insurance providers which further add to their popularity among end users.

However, in the forecast period, Bilevel PAP devices are expected to witness the fastest growth in demand due to the rising requirement of different pressure rate PAP devices for inhalation and exhalation, addressing a drawback associated with CPAP devices.

North America is expected to dominate the overall Positive Airway Pressure Devices Market:

Among all the regions, North America is expected to account for the largest share in the PAP devices market. This can be attributed to the growing prevalence of OSA, obesity, diabetes and the well-established reimbursement programs in the region are predicted to be the major influencing factors in driving the overall growth of the market over the forecast period.

The North American PAP devices market is expected to witness growth due to rising prevalence of obesity in North American countries, particularly in the US. As per the facts provided by the Centers for Disease Control and Prevention (2023), the countrywide prevalence of obesity in 2017-2018 was 42.4%. It further stated that the prevalence of severe obesity increased to 9.2% in the same time period. Obesity is linked with many other indications such as heart disease, stroke, and a major risk factor for sleep apnea. Therefore, this increase in obesity prevalence may be a major contributing factor in the growing demand for PAP devices in the country, and subsequently in the North American region.

Furthermore, the supportive reimbursement structure for the PAP devices has also been instrumental in the active adoption of these devices by end users. Many of the insurance providers in the US provide coverage for PAP devices, majorly the CPAP devices.

Considering the presence of large patient pool in the country for OSA and obesity coupled with supportive reimbursement and insurance structure for PAP devices, the market for PAP devices is predicted to witness significant growth in the North American region.

Positive Airway Pressure Devices Market Key Players:

Some of the key market players operating in the PAP Devices market includes ResMed, Koninklijke Philips N.V., Fisher & Paykel Healthcare Limited., APEX MEDICAL CORP, ARMSTRONG MEDICAL (an EAKIN Company), Smiths Medical, Compumedics Limited, VYAIRE MEDICAL, INC., Somnera Inc, 3B Medical Inc, DeVilbiss Healthcare LLC, Curative Medical Inc, Somnetics International, Inc, Lowenstein Medical UK Ltd., Beijing Aeonmed Co., Ltd., medin Medical Innovations GmbH, medicraft, Hebei Topson Medical Technology Ltd., Sefam, Lowenstein Medical Technology GmbH + Co. KG and others.

Recent Developmental Activities in Positive Airway Pressure Devices Market:

In September 2022, Koninklijke Philips N.V received the authorization from the US Food and Drug Administration for the initiation of the repairing of their first-generation DreamStation CPAP devices. These devices were previously recalled in June 2022 due to probable health issues in patients.

In August 2022, ResMed launched AirSense 11 PAP Series, the company's next-generation PAP device for sleep apnea management. The device includes features such as Care-In and Personal Therapy Assistant among other features.

In February 2022, 3B Medical Inc received the product approval from US Food and Drug Administration for their new third generation bi-level device- Luna G3 Auto-BPAP device. The device is indicated to be used in the treatment of obstructive sleep apnea.

Key Takeaways from the Positive Airway Pressure Devices Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Positive Airway Pressure Devices market.

Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years

Key companies dominating the Global Positive Airway Pressure Devices Market.

Various opportunities available for the other competitor in the Positive Airway Pressure Devices Market space.

What are the top performing segments in 2023? How these segments will perform in 2030.

Which is the top-performing regions and countries in the current Global Positive Airway Pressure Devices market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for Global Positive Airway Pressure Devices market growth in the coming future?

Target Audience who can be benefited from this Positive Airway Pressure Devices Market Report Study

Positive Airway Pressure Devices providers

Research organizations and consulting companies

Positive Airway Pressure Devices-related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in Positive Airway Pressure Devices

Various End-users who want to know more about the Positive Airway Pressure Devices Market and latest technological developments in the Positive Airway Pressure Devices market.

Frequently Asked Questions for Positive Airway Pressure Devices Market:

1. What is a Positive Airway Pressure Device?

PAP devices help in keeping the airways open for sleep apnea patients and prevent it from collapsing while they sleep thereby enabling them to breathe normally.

2. What is the market for Global Positive Airway Pressure Devices?

Global Positive Airway Pressure Devices Market was valued at USD 1.92 billion in 2020, growing at a CAGR of 8.40% during the forecast period from 2024 to 2030 to reach USD 3.12 billion by 2030.

3. What are the drivers for Global Positive Airway Pressure Devices Market?

The major drivers of the global positive airway pressure devices market growth are the increasing prevalence of obstructive sleep apnea, rising prevalence of neonatal respiratory distress syndrome, growing demand for non-invasive ventilation, and technological advancements in device development.

4. What are the key players operating in Global Positive Airway Pressure Devices Market?

Some of the major market players operating in the Positive Airway Pressure Devices market include ResMed, Koninklijke Philips N.V., Fisher & Paykel Healthcare Limited., APEX MEDICAL CORP, ARMSTRONG MEDICAL (an EAKIN Company), Smiths Medical, Compumedics Limited, VYAIRE MEDICAL, INC., Somnera Inc, 3B Medical Inc, DeVilbiss Healthcare LLC, Curative Medical Inc, Somnetics International, Inc, Lowenstein Medical UK Ltd., Beijing Aeonmed Co., Ltd., medin Medical Innovations GmbH,medicraft, Hebei Topson Medical Technology Ltd., Sefam, Lowenstein Medical Technology GmbH + Co. KG and others.

5. Which region has the highest share in Positive Airway Pressure Devices market?

North America is expected to dominate the overall Positive Airway Pressure Devices market during the forecast period, 2024 to 2030. This can be attributed to the growing prevalence of OSA, obesity, diabetes and the well-established reimbursement programs in the region are predicted to be the major influencing factors in driving the overall growth of the market over the forecast period.

Table of Contents

1. Positive Airway Pressure Devices Market Report Introduction

2. Positive Airway Pressure Devices Market Executive Summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment

3. Regulatory and Patent Analysis

• 3.1. The United States
• 3.2. Europe
• 3.3. Japan
• 3.4. China

4. Positive Airway Pressure Devices Market Key Factors Analysis

• 4.1. Positive Airway Pressure Devices Market Drivers
  • 4.1.1. Increasing Prevalence of Obstructive Sleep Apnea
  • 4.1.2. Growing Cases of Neonatal Respiratory Distress Syndrome
  • 4.1.3. Rising Demand for Non Invasive Ventilation
  • 4.1.4. Technological Advancements in Product Development
• 4.2. Positive Airway Pressure Devices Market Restraints and Challenges
  • 4.2.1. Frequent Product Recalls
  • 4.2.2. Risks Associated with PAP Devices
• 4.3. Positive Airway Pressure Devices Market Opportunities
  • 4.3.1. Improvement in Product Design and Safety

5. Positive Airway Pressure Devices Market Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Positive Airway Pressure Devices Market

7. Positive Airway Pressure Devices Market Layout

• 7.1. By Device Type
  • 7.1.1. CPAP Devices
  • 7.1.2. APAP Devices
  • 7.1.3. BiPAP Devices
  • 7.1.4. Others
• 7.2. By Age Group
  • 7.2.1. Adults
  • 7.2.2. Pediatrics
  • 7.2.3. Others
• 7.3. By End User
  • 7.3.1. Hospitals
  • 7.3.2. Clinics
  • 7.3.3. Homecare Settings
• 7.4. By Geography
  • 7.4.1. North America
    • 7.4.1.1. North America PAP Devices Market, by Country
    • 7.4.1.1.1. United States
    • 7.4.1.1.2. Canada
    • 7.4.1.1.3. Mexico
  • 7.4.2. Europe
    • 7.4.2.1. Europe PAP Devices Market, by Country
    • 7.4.2.1.1. France
    • 7.4.2.1.2. Germany
    • 7.4.2.1.3. United Kingdom
    • 7.4.2.1.4. Italy
    • 7.4.2.1.5. Spain
    • 7.4.2.1.6. Rest of Europe
  • 7.4.3. Asia-Pacific
    • 7.4.3.1. Asia-Pacific PAP Devices Market, by Country
    • 7.4.3.1.1. China
    • 7.4.3.1.2. Japan
    • 7.4.3.1.3. India
    • 7.4.3.1.4. Australia
    • 7.4.3.1.5. South Korea
    • 7.4.3.1.6. Rest of Asia Pacific
  • 7.4.4. Rest of the World (RoW)
    • 7.4.4.1. RoW PAP Devices Market, by Country
    • 7.4.4.1.1. Middle East
    • 7.4.4.1.2. Africa
    • 7.4.4.1.3. South America

8. Positive Airway Pressure Devices Market Company and Product Profiles

• 8.1. ResMed
  • 8.1.1. Company Overview
  • 8.1.2. Company Snapshot
  • 8.1.3. Financial Overview
  • 8.1.4. Product Listing
  • 8.1.5. Entropy
• 8.2. Koninklijke Philips N.V
  • 8.2.1. Company Overview
  • 8.2.2. Company Snapshot
  • 8.2.3. Financial Overview
  • 8.2.4. Product Listing
  • 8.2.5. Entropy
• 8.3. Fisher & Paykel Healthcare Limited
  • 8.3.1. Company Overview
  • 8.3.2. Company Snapshot
  • 8.3.3. Financial Overview
  • 8.3.4. Product Listing
  • 8.3.5. Entropy
• 8.4. APEX MEDICAL CORP
  • 8.4.1. Company Overview
  • 8.4.2. Company Snapshot
  • 8.4.3. Financial Overview
  • 8.4.4. Product Listing
  • 8.4.5. Entropy
• 8.5. ARMSTRONG MEDICAL (an EAKIN Company)
  • 8.5.1. Company Overview
  • 8.5.2. Company Snapshot
  • 8.5.3. Financial Overview
  • 8.5.4. Product Listing
  • 8.5.5. Entropy
• 8.6. Smiths Medical
  • 8.6.1. Company Overview
  • 8.6.2. Company Snapshot
  • 8.6.3. Financial Overview
  • 8.6.4. Product Listing
  • 8.6.5. Entropy
• 8.7. Compumedics Limited
  • 8.7.1. Company Overview
  • 8.7.2. Company Snapshot
  • 8.7.3. Financial Overview
  • 8.7.4. Product Listing
  • 8.7.5. Entropy
• 8.8. VYAIRE MEDICAL, INC
  • 8.8.1. Company Overview
  • 8.8.2. Company Snapshot
  • 8.8.3. Financial Overview
  • 8.8.4. Product Listing
  • 8.8.5. Entropy
• 8.9. Somnera Inc
  • 8.9.1. Company Overview
  • 8.9.2. Company Snapshot
  • 8.9.3. Financial Overview
  • 8.9.4. Product Listing
  • 8.9.5. Entropy
• 8.10. 3B Medical Inc
  • 8.10.1. Company Overview
  • 8.10.2. Company Snapshot
  • 8.10.3. Financial Overview
  • 8.10.4. Product Listing
  • 8.10.5. Entropy
• 8.11. DeVilbiss Healthcare LLC
  • 8.11.1. Company Overview
  • 8.11.2. Company Snapshot
  • 8.11.3. Financial Overview
  • 8.11.4. Product Listing
  • 8.11.5. Entropy
• 8.12. Curative Medical Inc,
  • 8.12.1. Company Overview
  • 8.12.2. Company Snapshot
  • 8.12.3. Financial Overview
  • 8.12.4. Product Listing
  • 8.12.5. Entropy
• 8.13. Somnetics International, Inc.
  • 8.13.1. Company Overview
  • 8.13.2. Company Snapshot
  • 8.13.3. Financial Overview
  • 8.13.4. Product Listing
  • 8.13.5. Entropy
• 8.14. Lowenstein Medical UK Ltd.
  • 8.14.1. Company Overview
  • 8.14.2. Company Snapshot
  • 8.14.3. Financial Overview
  • 8.14.4. Product Listing
  • 8.14.5. Entropy
• 8.15. Beijing Aeonmed Co., Ltd.
  • 8.15.1. Company Overview
  • 8.15.2. Company Snapshot
  • 8.15.3. Financial Overview
  • 8.15.4. Product Listing
  • 8.15.5. Entropy
• 8.16. medin Medical Innovations GmbH
  • 8.16.1. Company Overview
  • 8.16.2. Company Snapshot
  • 8.16.3. Financial Overview
  • 8.16.4. Product Listing
  • 8.16.5. Entropy
• 8.17. medicraft
  • 8.17.1. Company Overview
  • 8.17.2. Company Snapshot
  • 8.17.3. Financial Overview
  • 8.17.4. Product Listing
  • 8.17.5. Entropy
• 8.18. Hebei Topson Medical Technology Ltd.
  • 8.18.1. Company Overview
  • 8.18.2. Company Snapshot
  • 8.18.3. Financial Overview
  • 8.18.4. Product Listing
  • 8.18.5. Entropy
• 8.19. Sefam
  • 8.19.1. Company Overview
  • 8.19.2. Company Snapshot
  • 8.19.3. Financial Overview
  • 8.19.4. Product Listing
  • 8.19.5. Entropy
• 8.20. Lowenstein Medical Technology GmbH + Co. KG
  • 8.20.1. Company Overview
  • 8.20.2. Company Snapshot
  • 8.20.3. Financial Overview
  • 8.20.4. Product Listing
  • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us